Updated Jul 16, 2026
ROBBINS LARRY has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $4.65M. Lifetime open-market sales: $606.44M. Historical track record: 5/5 stars across 3 tracked purchases.

Larry Robbins is a corporate director whose activity appears in SEC insider filings for Butterfly Network, Inc. (BFLY) and CVS Health Corp (CVS). According to the context provided, he has held director roles and, in the latest disclosure dated 2025-12-05, reported zero purchases and zero sales across seven filings. This profile is generated from the SEC filing context rather than a widely public biography.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Links | Wikipedia |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 10000% |
| 90-day win rate | 10000% |
| Avg 5-day return | +223.48% |
| Avg 30-day return | +2640.13% |
| Avg 90-day return | +2616.03% |
| Best 30-day return | +2647.06% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | BFLY | Butterfly Network, Inc. | A — Grant or award | 25.4K | $0.00 | |
| 2026-05-21 | CVS | CVS HEALTH Corp | S — Open-market sale | 370.5K | $93.45 | $34.62M |
| 2026-05-21 | CVS | CVS HEALTH Corp | S — Open-market sale | 800 | $96.28 | $77K |
| 2026-05-21 | CVS | CVS HEALTH Corp | S — Open-market sale | 66.9K | $95.67 | $6.40M |
| 2026-05-21 | CVS | CVS HEALTH Corp | S — Open-market sale | 152.7K | $94.81 | $14.48M |
| 2026-05-21 | CVS | CVS HEALTH Corp | S — Open-market sale | 797.6K | $93.48 | $74.56M |
| 2026-05-21 | CVS | CVS HEALTH Corp | S — Open-market sale | 151 | $95.18 | $14K |
| 2026-05-21 | CVS | CVS HEALTH Corp | S — Open-market sale | 1.98M | $94.45 | $187.33M |
| 2025-12-05 | BFLY | Butterfly Network, Inc. | P — Open-market purchase | 200.0K | $3.06 | $611K |
| 2025-12-05 | BFLY | Butterfly Network, Inc. | P — Open-market purchase | 536.9K | $2.99 | $1.61M |
| 2025-12-05 | BFLY | Butterfly Network, Inc. | P — Open-market purchase | 821.6K | $2.96 | $2.43M |
| 2025-06-13 | BFLY | Butterfly Network, Inc. | A — Grant or award | 80.4K | $0.00 | |
| 2025-05-02 | CVS | CVS HEALTH Corp | S — Open-market sale | 150.0K | $66.67 | $10.00M |
| 2025-05-02 | CVS | CVS HEALTH Corp | S — Open-market sale | 97.0K | $67.99 | $6.60M |
| 2025-05-02 | CVS | CVS HEALTH Corp | S — Open-market sale | 1.23M | $67.37 | $82.65M |
| 2025-05-02 | CVS | CVS HEALTH Corp | S — Open-market sale | 373.8K | $69.66 | $26.04M |
| 2025-05-02 | CVS | CVS HEALTH Corp | S — Open-market sale | 222.6K | $68.38 | $15.22M |
| 2025-05-02 | CVS | CVS HEALTH Corp | S — Open-market sale | 1.68M | $67.39 | $113.19M |
Larry Robbins is a corporate director whose activity appears in SEC insider filings for Butterfly Network, Inc. (BFLY) and CVS Health Corp (CVS). According to the context provided, he has held director roles and, in the latest disclosure dated 2025-12-05, reported zero purchases and zero sales across seven filings. This profile is generated from the SEC filing context rather th…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 3 open-market purchases ($4.65M) and 14 open-market sales ($606.44M) across all tracked filings.
Across 3 tracked purchases, ROBBINS LARRY averaged +2640.1% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live ROBBINS LARRY profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.